Zobrazeno 1 - 10
of 92
pro vyhledávání: ''
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8483-8496 (2021)
Cancer Medicine
Cancer Medicine
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains controversial. In the present study, we aimed to investigate whether elderly patients with stage II–III EC could benefit from trimodal therapy. Methods The se
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Objective To investigate whether surgery improves prognosis in elderly patients with Merkel cell carcinoma (MCC). Materials/Methods Data of all patients with MCC diagnosed between 2004 and 2015 were extracted from the Surveillance, Epidemiology, and
Autor:
De Shen Wang, Long Bai, Han Zhou, Wan-Lan Huang, Ze-Yu Lin, Qin Chen, Yun-Le Wan, Yun-Xin Lu, Qi Meng, Chun-Ping Lin, Zhizhong Pan
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8005-8019 (2021)
Cancer Medicine
Cancer Medicine
Background The prognostic value of lactate dehydrogenase (LDH) in colorectal cancer patients has remained inconsistent between nonmetastatic and metastatic settings. So far, very few studies have included LDH in the prognostic analysis of curative‐
Autor:
Diego Serraino, Stefania Del Zotto, Lucia Fratino, Francesca Taboga, Luigino Dal Maso, Elena Clagnan, F Tosolini, A. Zucchetto, Ivana Burba
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 21, Pp 7781-7792 (2021)
Cancer Medicine, Vol 10, Iss 21, Pp 7781-7792 (2021)
Background It is well established that cancer patients infected with SARS‐CoV‐2 are at particularly elevated risk of adverse outcomes, but the comparison of SARS‐CoV‐2 infection risk between cancer patients and cancer‐free individuals has b
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 20, Pp 7048-7059 (2021)
Cancer Medicine, Vol 10, Iss 20, Pp 7048-7059 (2021)
This retrospective study has been conducted to validate the performance of deep learning‐based survival models in glioblastoma (GBM) patients alongside the Cox proportional hazards model (CoxPH) and the random survival forest (RSF). Furthermore, th
Autor:
Rajesh Balkrishnan, Aditya Narayan, Lucas E Flausino, Raj P Desai, Roger Chammas, Fabian Camacho
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5347-5357 (2021)
Cancer Medicine
Cancer Medicine
Purpose Colorectal cancer (CRC) diagnosis is associated with high mortality in the United States and thus warrants the study of novel treatment approaches. Vascular changes are well observed in cancers and evidence indicates that antihypertensive (AH
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Purpose To discuss whether the dome or anterior wall of bladder adenocarcinoma (BAC) should be classified into urachal carcinoma (UrC) and the relationship of primary tumor location (PTL) as well as treatment with survival. Methods Surveillance, Epid
Autor:
Nirav Patil, Ankit Mangla, Asrar Alahmadi, Nelroy Jones, Richard T. Lee, David L. Bajor, Jill S. Barnholtz-Sloan, Eva Selfridge, Amr Mohamed, Gino Cioffi, Aman Opneja, Tin-Yun Tang, Joel N. Saltzman
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4397-4404 (2021)
Cancer Medicine
Cancer Medicine
Background This study analyzes the pattern of use of single agent anticancer therapy (SAACT) in the treatment and survival of advanced hepatocellular carcinoma (aHCC) before and after sorafenib was FDA approved in 2007. Methods Adult patients diagnos
Autor:
Takeshi Yamada, Kosuke Shimizu, Yu Osaki, Maki Fujiwara, Hiroshi Kitamura, Osamu Ogawa, Atsushi Takahashi, Kazumasa Matsumoto, Hiromasa Araki, Katsuhiro Ito, Ryotaro Tomida, Takahiro Kojima, Ryoma Kurahashi, Kensuke Hikami, Hiroyuki Nishiyama, Takashige Abe, Yu Tashiro, Takashi Kobayashi, Shuichi Tatarano, Akira Yokomizo, Naoto Sassa, Kosuke Ogawa, Kenji Nakamura, Masayuki Uegaki, Kazunari Tsuchihashi, Junichi Inokuchi
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 10, Pp 3188-3196 (2021)
Cancer Medicine, Vol 10, Iss 10, Pp 3188-3196 (2021)
Background The benefits of pembrolizumab in patients with advanced urothelial carcinoma (UC) and impaired performance status (PS) remain unknown. This study assessed the safety and efficacy of pembrolizumab in patients with platinum‐refractory UC a
Autor:
Hayet Amalou, Michal Mauda-Havakuk, Nidhi Jain, Elliot Levy, Bradford J. Wood, Maureen Edgerly, Tito Fojo, Elizabeth Levin, Michael S. Hughes, Victoria L. Anderson, Jaydira Del Rivero, Venkatesh Krishnasamy, Paul Wakim
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 7, Pp 2259-2267 (2021)
Cancer Medicine, Vol 10, Iss 7, Pp 2259-2267 (2021)
Background To evaluate outcomes and survival rates in patients with metastatic adrenocortical carcinoma (ACC) who were treated with image‐guided locoregional treatments (IGLTs). Purpose To evaluate the overall survival (OS) and clinical impact of I